$MDT (Medtronic plc)

$MDT {{ '2015-07-07T15:17:10+0000' | timeago}} • SEC

$MDT FY15 10-K: Net Sales: Cardiac and Vascular Group, $9,361MM, up 6% from $8,847MM in FY14. Minimally Invasive Therapies Group, $2,387MM. Restorative Therapies Group, $6,751MM, up 4% from $6,501MM. Diabetes Group, $1,762MM, up 6% from $1,657MM in FY14. Increase in net sales was primarily attributable to Covidien acquisition.

$MDT {{ '2017-11-22T20:29:59+0000' | timeago}} • Webcast

In Oct., Animas announced to cease the manufacture and sale of its insulin pumps and partnered with $MDT to offer its customers the opportunity to transfer to a new device.With $JNJ exiting the insulin pump market in the US and Canada, $MDT now has access to the 90,000 patients who use Animas insulin pumps.

$MDT {{ '2017-11-22T20:27:57+0000' | timeago}} • Webcast

$MDT got US FDA approval for its MiniMed 670G hybrid closed-loop system and rolled the device out in a Priority Access program. It began shipping systems to patients in June. The company now expects growth to significantly improve in 3Q18 as it has finished shipping pumps for the program.

$MDT {{ '2017-11-21T17:06:41+0000' | timeago}} • Announcement

Given the recent events of hurricanes and wildfires, $MDT managed to restrict its revenue decline to just 4% for 2Q18. The medical-device maker saw its profit grow 81% on a GAAP basis. On adjusted basis, earnings fell 4% to $1.07 per share.

$MDT {{ '2017-11-21T12:59:44+0000' | timeago}} • Infographic

$MDT Medtronic plc Earnings AlphaGraphic: Q2 2018 Highlights

$MDT {{ '2017-11-09T13:05:42+0000' | timeago}} • Announcement

Preliminary 2Q18 Results: $MDT worldwide revenue declined 4% to approx. $7.05Bil, with the decline driven by the company's divestiture of its Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to $CAH. The company expects the impact of Hurricane Maria to be approx. $0.03 to non-GAAP EPS for 2Q18.

$MDT {{ '2017-11-06T11:28:57+0000' | timeago}} • Announcement

$MDT has received CE Mark for the world's smallest fully implantable spinal cord stimulator "Intellis" for both Spinal Cord Stimulation and Peripheral Nerve Stimulation as an aid in the management of certain types of chronic pain.

$ISRG {{ '2017-10-19T21:40:26+0000' | timeago}} • Announcement

Worldwide da Vinci procedures grew approx. 15% in 3Q17 as $ISRG shipped 169 da Vinci Surgical Systems during the quarter. With $TRXC already in its sight, Intuitive Surgical will also be eyeing $MDT with much more concern as Medtronic is set to roll out its surgical robot system next year.

$MDT {{ '2017-10-16T20:09:05+0000' | timeago}} • Announcement

$MDT said its Medtronic Care Management Services (MCMS) business and American Well entered into a strategic partnership. Under the agreement, the businesses will work together to enable patient access to American Well's telemedicine services on MCMS' video-enabled platforms, and to allow bi-directional data flow between the two parties.

$JNJ {{ '2017-10-05T13:58:49+0000' | timeago}} • Announcement

Animas Corp., a $JNJ Diabetes Care Companies, plans to discontinue the manufacturing and sale of Animas Vibe and OneTouch Ping insulin pumps, close operations and exit the insulin pump business. Animas has selected $MDT as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers.

$HRC {{ '2017-10-05T12:06:47+0000' | timeago}} • Announcement

Chairman of $HRC Board Rolf Classon will not stand for re-election to the BoD when his current term expires on March 6, 2018. The Board plans to appoint current independent director William Dempsey to this role if he is re-elected by shareholders. The company also elected Gary Ellis, retired CFO and SVP of $MDT, to its BoD, effective Oct 5, 2017.

$AMAG {{ '2017-09-29T12:41:24+0000' | timeago}} • Announcement

$AMAG announced the appointment of Tracy Palmer Berns as Chief Compliance Officer, with immediate effect. She will report to Joseph Vittiglio, General Counsel and SVP of Legal Affairs and Quality. Berns was the VP of Ethics and Compliance at the Minimally Invasive Therapies Group at $MDT.

$MDT {{ '2017-09-18T13:29:52+0000' | timeago}} • Announcement

$MDT announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow.

$MDT {{ '2017-09-11T12:01:51+0000' | timeago}} • Announcement

$MDT voluntarily recalls specific lots of infusion sets used with all models of Medtronic insulin pumps due to a certain discontinued component. The recall comes after reports from patients that a component, the vent membrane, may be susceptible to being blocked by fluid during priming and fill-tubing, which can lead to over-delivery of insulin.

$MDT {{ '2017-09-08T11:44:21+0000' | timeago}} • Announcement

$MDT's IN.PACT Admiral Drug-Coated Balloon received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of peripheral artery disease in the upper leg. Before $MDT can begin commercialization, it must partner with Japanese MHLW to gain reimbursement to ensure broader access to this therapy.

$MDT {{ '2017-09-05T15:49:22+0000' | timeago}} • Announcement

$MDT launched a long-term clinical study of its INFUSE Bone Graft for use during Posterolateral Fusion (PLF) and Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. The first patient has been enrolled in the PLF study. The 10-year program is looking to enroll 550-700 individuals between the pilot and pivotal studies of both procedures.

$MDT {{ '2017-08-29T14:48:11+0000' | timeago}} • Webcast

On the IT disruption, $MDT said it is very difficult to separate and quantify the impact related to the outage. The company did say that the outage is not material to 1Q18 revenue or EPS, but stated that it is "very difficult to quantify beyond that."

$MDT {{ '2017-08-29T14:41:58+0000' | timeago}} • Webcast

$MDT said it is not really focused on transformative M&A, but will continue to have a disciplined approach to pursuing tuck-in acquisitions. Notably, the company is still in the last year of integration of Covidien.

$MDT {{ '2017-08-29T14:29:13+0000' | timeago}} • Webcast

$MDT's overall sensor unit demand has more than doubled in the past 10 quarters since launching the MiniMed 640G. The company now expects to see increasing revenue momentum from several new product launches over the balance of the fiscal year 2018.

$MDT {{ '2017-08-22T14:09:01+0000' | timeago}} • Announcement

$MDT maintains its FY18 earnings and revenue forecasts. The company sees non-GAAP EPS to increase 9-10% and revenue to increase 4-5% on a constant-currency basis.

$MDT {{ '2017-08-22T14:06:57+0000' | timeago}} • Announcement

On June, $MDT experienced an IT system disruption, impacting customer ordering, distribution, and manufacturing processes globally. The company said that the IT disruption did have some impact on the overall performance for 1Q18, but it was not material to revenue or earnings.

Recent Transcripts

MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
RMTI (Rockwell Medical, Inc.)
Wednesday, November 8 2017 - 9:30pm
ELMD (Electromed, Inc.)
Wednesday, November 8 2017 - 2:00pm
VCEL (Vericel Corporation)
Tuesday, November 7 2017 - 1:00pm
PTLA (Portola Pharmaceuticals, Inc.)
Monday, November 6 2017 - 9:30pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, November 3 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Thursday, November 2 2017 - 9:00pm
LIVN (LivaNova PLC)
Thursday, November 2 2017 - 1:00pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
MASI (Masimo Corporation)
Tuesday, October 31 2017 - 8:30pm
CRY (CryoLife Inc.)
Tuesday, October 31 2017 - 12:00pm
ROP (Roper Technologies, Inc.)
Monday, October 30 2017 - 12:30pm
MSFT (Microsoft Corporation)
Thursday, October 26 2017 - 9:30pm
CYTK (Cytokinetics, Incorporated)
Thursday, October 26 2017 - 8:30pm
GILD (Gilead Sciences Inc.)
Thursday, October 26 2017 - 8:30pm
BMY (Bristol-Myers Squibb Company)
Thursday, October 26 2017 - 2:30pm
AMGN (Amgen Inc)
Wednesday, October 25 2017 - 9:00pm

AlphaGraphics you may like